Ozurdex

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA022315 None Intravitreal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ozurdex ® Is A Corticosteroid Indicated For: The Treatment Of Macular Edema Following Branch Retinal Vein Occlusion (Brvo) Or Central Retinal Vein Occlusion (Crvo) ( 1.1 ) The Treatment Of Non-Infectious Uveitis Affecting The Posterior Segment Of The Eye ( 1.2 ) The Treatment Of Diabetic Macular Edema ( 1.3 ) 1.1 Retinal Vein Occlusion Ozurdex ® (Dexamethasone Intravitreal Implant) Is Indicated For The Treatment Of Macular Edema Following Branch Retinal Vein Occlusion (Brvo) Or Central Retinal Vein Occlusion (Crvo). 1.2 Posterior Segment Uveitis Ozurdex ® Is Indicated For The Treatment Of Non-Infectious Uveitis Affecting The Posterior Segment Of The Eye. 1.3 Diabetic Macular Edema Ozurdex ® Is Indicated For The Treatment Of Diabetic Macular Edema.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dexamethasone DEXAMETHASONE ZINC4654654

Comments